Parallax Volatility Advisers, L.P. Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $614,454 - $721,056	-600 Reduced 5.94%	9,500 $9.99 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $11 Million - $13.4 Million	-12,500 Reduced 55.31%	10,100 $10.6 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $15 Million - $16.5 Million	-16,600 Reduced 42.35%	22,600 $21.8 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $9.53 Million - $10.8 Million	-12,300 Reduced 23.88%	39,200 $34.4 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $28.7 Million - $35 Million	41,400 Added 409.9%	51,500 $42.4 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $140,006 - $166,070	200 Added 2.02%	10,100 $7.26 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $8.91 Million - $10.8 Million	-13,100 Reduced 56.96%	9,900 $8.13 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $5.58 Million - $6.05 Million	-7,900 Reduced 25.57%	23,000 $16.6 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $10 Million - $12.7 Million	17,500 Added 130.6%	30,900 $21.3 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $7.35 Million - $9.9 Million	13,400 New	13,400 $7.92 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $11.7 Million - $14.4 Million	-21,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $4.62 Million - $5.7 Million	8,500 Added 65.38%	21,500 $13.6 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $13.1 Million - $15.6 Million	-22,900 Reduced 63.79%	13,000 $7.87 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $5.6 Million - $7.11 Million	-11,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $17.2 Million - $21.8 Million	35,900 New	35,900 $17.3 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $6.37 Million - $7.7 Million	11,700 New	11,700 $6.55 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $147,996 - $193,176	-300 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $12.1 Million - $17.8 Million	-36,000 Reduced 99.17%	300 $146,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $9.59 Million - $13.2 Million	35,000 Added 2692.31%	36,300 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $21.6 Million - $25.2 Million	-79,100 Reduced 98.38%	1,300 $360,000
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $19.9 Million - $27.5 Million	66,400 Added 474.29%	80,400 $25.2 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $24.3 Million - $28.7 Million	-65,300 Reduced 82.35%	14,000 $5.75 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $6.62 Million - $7.94 Million	19,700 Added 33.05%	79,300 $29.6 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $561,824 - $653,616	1,600 Added 2.76%	59,600 $24.1 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $9.39 Million - $11.4 Million	33,000 Added 132.0%	58,000 $20 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $4.11 Million - $5.12 Million	13,000 Added 108.33%	25,000 $8.61 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $358,630 - $469,950	-1,000 Reduced 7.69%	12,000 $4.51 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $5.61 Million - $6.55 Million	13,000	13,000 $5.81 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account